Literature DB >> 19717150

Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.

Mireia Junyent1, Rosa Gilabert, Estíbaliz Jarauta, Isabel Núñez, Montserrat Cofán, Fernando Civeira, Miguel Pocoví, Miguel Mallén, Daniel Zambón, Fátima Almagro, Juan Vega, Diego Tejedor, Emilio Ros.   

Abstract

BACKGROUND AND OBJECTIVES: Defects in the low-density lipoprotein receptor (LDLR) gene cause familial hypercholesterolemia (FH), a highly atherogenic condition. The effect of different LDLR mutations on coronary heart disease (CHD) risk is insufficiently defined. We assessed carotid intima-media thickness (IMT), a surrogate marker of CHD, in relation to LDLR mutational class in FH.
METHODS: In 436 Spanish FH patients (223 men and 213 women, age 44+/-14 years) with known LDLR mutations, alleles were classified by standard criteria as null (n=269), defective (n=162), or undetermined (n=5). LDLR defects were detected using a microarray (Lipochip) designed to uncover prevalent mutations in Spain and gene sequencing when no mutations were detected. Carotid IMT and plaque were assessed in FH patients and 268 healthy subjects.
RESULTS: All carotid measurements were increased in FH patients versus controls (p<0.05), irrespective of genotype. After adjustment for gender and age, patients with null alleles compared with defective alleles had similar mean and maximum common carotid artery (CCA) IMT, but higher maximum IMT at any carotid segment, with median values (95% confidence interval) of 1.25 mm (1.19-1.31) and 1.11 mm (1.05-1.18), respectively. Multivariate analysis showed that null alleles were independently associated with maximum CCA-IMT (beta=0.09, p=0.033) with an impact similar to that of gender (beta=0.10, p=0.035).
CONCLUSIONS: FH patients show advanced carotid atherosclerosis in relation to LDLR mutational class. The findings support the utility of genetic testing in FH beyond providing a secure diagnosis. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717150     DOI: 10.1016/j.atherosclerosis.2009.07.058

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.

Authors:  Antonios P Vlahos; Katerina K Naka; Aris Bechlioulis; Paraskevi Theoharis; Konstantinos Vakalis; Elisavet Moutzouri; George Miltiadous; Lampros K Michalis; Antigoni Siamopoulou-Mavridou; Moses Elisaf; Haralampos J Milionis
Journal:  Pediatr Cardiol       Date:  2013-07-03       Impact factor: 1.655

2.  Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes.

Authors:  D M Kusters; R Huijgen; J C Defesche; M N Vissers; I Kindt; B A Hutten; J J P Kastelein
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

3.  Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?

Authors:  Eduardo Mansilla; Vanina Díaz Aquino; Daniel Zambón; Gustavo Horacio Marin; Karina Mártire; Gustavo Roque; Thomas Ichim; Neil H Riordan; Amit Patel; Flavio Sturla; Gustavo Larsen; Rubén Spretz; Luis Núñez; Carlos Soratti; Ricardo Ibar; Michiel van Leeuwen; José María Tau; Hugo Drago; Alberto Maceira
Journal:  Stem Cells Int       Date:  2011-06-13       Impact factor: 5.443

4.  Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation.

Authors:  Di Sun; Bing-Yang Zhou; Sha Li; Ning-Ling Sun; Qi Hua; Shu-Lin Wu; Yun-Shan Cao; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Ying Gao; Chuan-Jue Cui; Geng Liu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2018-11-06       Impact factor: 3.876

5.  Longitudinal evaluation of endothelial markers in children and adolescents with familial hypercholesterolemia.

Authors:  Patrizia Bruzzi; Barbara Predieri; Simona Madeo; Francesca Lami; Lorenzo Iughetti
Journal:  Acta Biomed       Date:  2021-11-03

6.  The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.

Authors:  Isabel De Castro-Orós; Miguel Pocoví; Fernando Civeira
Journal:  Appl Clin Genet       Date:  2010-08-05

Review 7.  Cardiovascular risk stratification in familial hypercholesterolaemia.

Authors:  Mahtab Sharifi; Roby D Rakhit; Steve E Humphries; Devaki Nair
Journal:  Heart       Date:  2016-04-28       Impact factor: 5.994

8.  Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation.

Authors:  Roberto Scicali; Antonino Di Pino; Chiara Pavanello; Alice Ossoli; Arianna Strazzella; Antonia Alberti; Stefania Di Mauro; Alessandra Scamporrino; Francesca Urbano; Agnese Filippello; Salvatore Piro; Agata Maria Rabuazzo; Laura Calabresi; Francesco Purrello
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.